Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas

Pancreas

Volumn 41, Issue 2, 2012, Pages 169-174

  Corcos, Olivier ^a   Couvelard, Anne ^a,b   Dargère, Delphine ^a   Sauvanet, Alain ^c   Hammel, Pascal ^a   Paradis, Valérie ^a,b   Lévy, Philippe ^a   Ruszniewski, Philippe ^a   Bedossa, Pierre ^a,b  

^a BEAUJON HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

cancer; intraductal papillary mucinous neoplasms; pancreas; proteome

Indexed keywords

PROTEOME;

ADULT; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MALIGNANT TRANSFORMATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MUCUS; PANCREAS ISLET CELL CARCINOMA; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; CARCINOMA, PANCREATIC DUCTAL; EARLY DETECTION OF CANCER; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MUCUS; NEOPLASM GRADING; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84857912562     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182289356     Document Type: Article

References (33)

1. emal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin. 2003;53(1):5-26.
2. Bernard P, Scoazec JY, Joubert M, et al. Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases. Arch Surg. 2002;137(11):1274-1278. (Pubitemid 35345902)
3. Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447(5):794-799. (Pubitemid 41728866)
4. Kloppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology. 2001;1(6):648-655. (Pubitemid 33674962)
5. Kloppel G, Luttges J. WHO classification 2000: exocrine pancreatic tumors. Verh Dtsch Ges Pathol. 2001;85:219-228.
6. Schonleben F, Qiu W, Ciau NT, et al. PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas. Clin Cancer Res. 2006;12(12):3851-3855. (Pubitemid 44000267)
7. Schonleben F, Qiu W, Bruckman KC, et al. BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas. Cancer Lett. 2007;249(2):242-248. (Pubitemid 46452934)
8. Maire F, Hammel P, Terris B, et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut. 2002;51(5):717-722. (Pubitemid 35216862)
9. Levy P, Jouannaud V, O'Toole D, et al. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol. 2006;4(4):460-468.
10. Irie H, Honda H, Aibe H, et al. MR cholangiopancreatographic differentiation of benign and malignant intraductal mucin-producing tumors of the pancreas. AJR Am J Roentgenol. 2000;174(5): 1403-1408. (Pubitemid 30261800)
11. Taouli B, Vilgrain V, Vullierme MP, et al. Intraductal papillary mucinous tumors of the pancreas: helical CT with histopathologic correlation. Radiology. 2000;217(3):757-764.
12. Taouli B, Vilgrain V, O'Toole D, et al. Intraductal papillary mucinous tumors of the pancreas: features with multimodality imaging. J Comput Assist Tomogr. 2002;26(2):223-231. (Pubitemid 34233369)
13. Aithal GP, Chen RY, Cunningham JT, et al. Accuracy of EUS for detection of intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc. 2002;56(5):701-707. (Pubitemid 36531706)
14. Sugiyama M, Izumisato Y, Abe N, et al. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg. 2003;90(10):1244-1249. (Pubitemid 37330429)
15. Maire F, Couvelard A, Hammel P, et al. Intraductal papillary mucinous tumors of the pancreas: the preoperative value of cytologic and histopathologic diagnosis. Gastrointest Endosc. 2003;58(5):701-706. (Pubitemid 37370483)
16. Rautou PE, Levy P, Vullierme MP, et al. Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study. Clin Gastroenterol Hepatol. 2008;6(7):807-814.
17. Jr GW, Cazares LH, Leung SM, et al. Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis. 1999;2(5/6):264-276. (Pubitemid 30252204)
18. Alexe G, Alexe S, Liotta LA, et al. Ovarian cancer detection by logical analysis of proteomic data. Proteomics. 2004;4(3):766-783. (Pubitemid 38339155)
19. Paradis V, Degos F, Dargere D, et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology. 2005;41(1):40-47. (Pubitemid 40066381)
20. Guedj N, Dargere D, Degos F, et al. Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion. Lab Invest. 2006;86(9):951-958. (Pubitemid 44268169)
21. Zhukov TA, Johanson RA, Cantor AB, et al. Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer. 2003;40(3):267-279. (Pubitemid 36627706)
22. Casado B, Iadarola P, Pannell LK. Preparation of nasal secretions for proteome analysis. Methods Mol Biol. 2008;425:77-87.
23. Debat H, Eloit C, Blon F, et al. Identification of human olfactory cleft mucus proteins using proteomic analysis. J Proteome Res. 2007;6(5):1985-1996. (Pubitemid 46814519)
24. Scarlett CJ, Smith RC, Saxby A, et al. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology. Gastroenterology. 2006;130(6):1670-1678. (Pubitemid 43668861)
25. Qi T, Han J, Cui Y, et al. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas. J Clin Pathol. 2008;61(1):49-58. (Pubitemid 351158225)
26. Shekouh AR, Thompson CC, Prime W, et al. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics. 2003;3(10):1988-2001. (Pubitemid 37305893)
27. Shen J, Person MD, Zhu J, et al. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 2004;64(24):9018-9026. (Pubitemid 39665512)
28. van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc. 2005;62(3):383-389. (Pubitemid 41187940)
29. Frossard JL, Amouyal P, Amouyal G, et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol. 2003;98(7):1516-1524. (Pubitemid 36875343)
30. Pais SA, Attasaranya S, Leblanc JK, et al. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology. Clin Gastroenterol Hepatol. 2007;5(4):489-495. (Pubitemid 46575363)
31. Aljebreen AM, Romagnuolo J, Perini R, et al. Utility of endoscopic ultrasound, cytology and fluid carcinoembryonic antigen and CA 19-9 levels in pancreatic cystic lesions. World J Gastroenterol. 2007;13(29):3962-3966. (Pubitemid 47272492)
32. Tanno S, Nakano Y, Nishikawa T, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut. 2008;57(3):339-343. (Pubitemid 351288099)
33. Uehara H, Nakaizumi A, Ishikawa O, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 2008;57(11): 1561-1565. Epub 2008 May 13.